Tirzepatide/Cyanocobalamin
Powerful new obesity drug poised to upend weight loss care.
Tirzepatide/Cyanocobalamin (which is sold under the brand name Mounjaro) is a first-in-class medicine that is a “dual agonist” weight loss treatment that can cause people to lose even more weight than those who use single-agonist medications, like Semaglutide. Tirzepatide/Cyanocobalamin stimulates hormones that control blood sugar levels and reduce appetite, triggering weight loss. If you have a higher percentage of body fat, Tirzepatide/Cyanocobalamin may be for you.
How does Tirzepatide/Cyanocobalaminwork?
Tirzepatide/Cyanocobalamin mimics two hormones naturally produced in the body: glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide (GIP).
Semaglutide/Cyanocobalamin simulates only GLP-1, whereas Tirzepatide/Cyanocobalamin imitates both hormones (GLP-1 and GIP). Researchers believe Tirzepatide/Cyanocobalamin may be so effective at lowering blood sugar levels and inducing weight loss because the two hormones it imitates work in a synergistic way.
Like Semaglutide/Cyanocobalamin, Tirzepatide/Cyanocobalamin slows the emptying of the stomach, making people feel full for longer. Tirzepatide/Cyanocobalamin also inhibits the brain’s hunger signals, suppressing appetite.
Introductory Offer – Only $799 For 8-Week Program
(Includes consultations, body analysis, all lab work and weekly injections and ongoing program maintenance and weekly injections)
Price is for new Tirzepatide patients only. If you are already taking Tirzepatide from Total Med Solutions or another provider, your price will vary depending on your dosage.
Tirzepatide is an Innovative NEW Medication!
What is the difference between Tirzepatide and Semaglutide?
GLP-1 drugs such as Tirzepatide, Mounjaro, Semaglutide and Ozempic are a group of new drugs that mimic GLP-1, a hormone the body releases after a meal, signaling you are full and thus lowering your overall appetite. However, Tirzepatide is unique because it attaches two different receptors (GLP-1 and GIP), unlike Semaglutide and Ozempic which only attach to one. Due to its unique dual activity, is why it’s called a “dual-agonist”. Tirzepatide has shown that it can increase weight loss for people who have a higher percentage of body fat.
